Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity Publisher Pubmed



Abolhassani H1, 2, 3 ; Wang Y1 ; Hammarstrom L1, 2 ; Panhammarstrom Q1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Division of Clinical Immunology, Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
  2. 2. Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden
  3. 3. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Science, Tehran, Iran

Source: Frontiers in Immunology Published:2021


Abstract

Inborn Errors of Immunity (IEI) comprise more than 450 inherited diseases, from which selected patients manifest a frequent and early incidence of malignancies, mainly lymphoma and leukemia. Primary antibody deficiency (PAD) is the most common form of IEI with the highest proportion of malignant cases. In this review, we aimed to compare the oncologic hallmarks and the molecular defects underlying PAD with other IEI entities to dissect the impact of avoiding immune destruction, genome instability, and mutation, enabling replicative immortality, tumor-promoting inflammation, resisting cell death, sustaining proliferative signaling, evading growth suppressors, deregulating cellular energetics, inducing angiogenesis, and activating invasion and metastasis in these groups of patients. Moreover, some of the most promising approaches that could be clinically tested in both PAD and IEI patients were discussed. © Copyright © 2021 Abolhassani, Wang, Hammarstrom and Pan-Hammarstrom.
2. Inborn Errors of Immunity and Cancers, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
4. Common Presentations and Diagnostic Approaches, Stiehm's Immune Deficiencies: Inborn Errors of Immunity (2020)
7. Updates of Cancer Hallmarks in Patients With Inborn Errors of Immunity, Current Opinion in Allergy and Clinical Immunology (2022)
Experts (# of related papers)
Other Related Docs
15. Application of Flow Cytometry in Predominantly Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
21. Respiratory Complications in Patients With Hyper Igm Syndrome, Journal of Clinical Immunology (2019)
22. Role of Rare Immune Cells in Common Variable Immunodeficiency, Pediatric Allergy and Immunology (2022)
27. General Considerations, Pulmonary Manifestations of Primary Immunodeficiency Diseases (2018)
28. Primary Immunodeficiencies and Cancers, Cancer Immunology: A Translational Medicine Context (2015)
29. Congenital Neutropenia and Primary Immunodeficiency Diseases, Critical Reviews in Oncology/Hematology (2019)
30. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, Journal of Investigational Allergology and Clinical Immunology (2017)
31. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort, Journal of Allergy and Clinical Immunology: In Practice (2019)
33. New Presentation of Cd27 Deficiency; Coronary Ectasia and Covid-19, Iranian Journal of Allergy# Asthma and Immunology (2023)
34. The Clinical and Immunological Features of Patients With Primary Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2018)
44. Tumor Immunology, Clinical Immunology (2022)
48. Management of Inborn Errors of Immunity in the Genomic Era, Turkish Archives of Pediatrics (2022)